Investigational Products for BA/BE [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2005-10-19 13:22 (6756 d 08:11 ago) – Posting: # 43
Views: 20,217

Hi!

'Preparation of Comparative Bioavailability Information for Drug Submissions in the CTD Format' (Draft Guidance, 2004-05-12) states:

Retention of Samples
It is recommended that samples of the test and reference drug products used in the comparative bioavailability study(ies), and the biological samples collected, including QC samples, be retained until the submission is either cleared or withdrawn.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,669 registered users;
57 visitors (0 registered, 57 guests [including 3 identified bots]).
Forum time: 21:34 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5